Search results for: 'Hardware-In-The-Loop Market'

02 Dec 2020  |  South Asia, Middle East & North Africa  |  Market Research

Rise of Virtual Visits Transforming the Telehealth Market in India

Telehealth Set to Emerge as the Next Multi-Million Dollar Growth Opportunity for the Healthcare Market in India

Infographics

×

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the Indian Telehealth market, highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The Telehealth market covered in this study includes three major segments—virtual visits, mHealth, ...

The global healthcare cloud market is expanding as healthcare organizations move beyond early cloud adoption and begin to use cloud environments as a foundation for managing data, enabling interoperability, and supporting more integrated clinical and operational workflows. As adoption matures, cloud is increasingly being positioned not just as infr...

The Healthcare IT Outlook 2026 examines the industry’s transition from experimentation to enterprise-scale execution, as artificial intelligence (AI), workflow orchestration, and platform consolidation reshape clinical, operational, and financial workflows. Following several years of pilot-led innovation, 2026 marks a pivotal inflection point where...

The global healthcare RTLS market is evolving beyond traditional asset tracking toward intelligent location platforms that enable real-time visibility, workflow optimization, and operational decision-making across healthcare environments. As healthcare providers continue investing in digital transformation, RTLS is increasingly being deployed as an...

02 Sep 2025  |  Global  |  Technology Research

Technological Advances in Engineered Cell Therapies, Global, 2025–2029

Emerging Trends and Technologies in Engineered Cell Therapies

Infographics

×

Engineered cell therapies have become a revolutionary medical field, surpassing conventional methods such as systemic medications and prominent immunosuppression to provide long-lasting, programmable, and targeted treatments for complicated diseases. Recent technical developments in engineered cell therapies examine how the rapid growth of cell eng...

Women’s health is moving beyond single-condition apps and episodic visits toward connected care that follows each life stage—from adolescence to pregnancy and postpartum, through perimenopause and healthy aging. What makes this feasible now is the convergence of policy tailwinds (e.g., expanded postpartum coverage), AI+ at-home diagnostics (earlie...

The healthcare cloud market is undergoing rapid transformation, driven by strategic imperatives that will redefine industry dynamics in 2026. Frost & Sullivan’s analysis identifies 10 critical shifts shaping this evolution, anchored in technological innovation, regulatory compliance, and operational resilience. Cloud adoption is no longer limited t...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

This study charts how digital health ecosystems are likely to form and scale through 2040 and what that implies for providers, payers, technology vendors, and retail/community partners. We define a digital health ecosystem as an interoperable platform that coordinates people, data, and decisions across home, retail, and hospital settings—secured by...